Bill Text: IA HF732 | 2019-2020 | 88th General Assembly | Amended
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: A bill for an act relating to the medical cannabidiol Act. (Formerly HSB 244.) Vetoed 5-24-19.
Spectrum: Committee Bill
Status: (Vetoed) 2019-05-24 - Vetoed by Governor. H.J. 1093. [HF732 Detail]
Download: Iowa-2019-HF732-Amended.html
Bill Title: A bill for an act relating to the medical cannabidiol Act. (Formerly HSB 244.) Vetoed 5-24-19.
Spectrum: Committee Bill
Status: (Vetoed) 2019-05-24 - Vetoed by Governor. H.J. 1093. [HF732 Detail]
Download: Iowa-2019-HF732-Amended.html
House
File
732
-
Reprinted
HOUSE
FILE
732
BY
COMMITTEE
ON
PUBLIC
SAFETY
(SUCCESSOR
TO
HSB
244)
(As
Amended
and
Passed
by
the
House
March
26,
2019
)
A
BILL
FOR
An
Act
relating
to
the
medical
cannabidiol
Act.
1
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
2
HF
732
(3)
88
ss/rh/md
H.F.
732
Section
1.
Section
124E.2,
subsection
2,
paragraph
i,
Code
1
2019,
is
amended
to
read
as
follows:
2
i.
Untreatable
Severe
or
chronic
pain.
3
Sec.
2.
Section
124E.2,
subsections
5
and
6,
Code
2019,
are
4
amended
to
read
as
follows:
5
5.
“Health
care
practitioner”
means
an
individual
licensed
6
under
chapter
148
to
practice
medicine
and
surgery
or
7
osteopathic
medicine
and
surgery
,
a
physician
assistant
8
licensed
under
chapter
148C,
or
an
advanced
registered
nurse
9
practitioner
licensed
under
chapter
152
or
152E,
who
is
a
10
patient’s
primary
care
provider.
“Health
care
practitioner”
11
shall
not
include
a
physician
assistant
licensed
under
chapter
12
148C
or
an
advanced
registered
nurse
practitioner
licensed
13
pursuant
to
chapter
152
or
152E
.
14
6.
“Medical
cannabidiol”
means
any
pharmaceutical
15
grade
cannabinoid
found
in
the
plant
Cannabis
sativa
L.
or
16
Cannabis
indica
or
any
other
preparation
thereof
that
has
17
a
tetrahydrocannabinol
level
of
no
more
than
three
percent
18
and
that
is
delivered
in
a
form
recommended
by
the
medical
19
cannabidiol
board,
approved
by
the
board
of
medicine,
and
20
adopted
by
the
department
pursuant
to
rule.
21
Sec.
3.
Section
124E.2,
subsection
8,
Code
2019,
is
amended
22
by
striking
the
subsection.
23
Sec.
4.
Section
124E.4,
subsection
1,
paragraph
f,
Code
24
2019,
is
amended
by
striking
the
paragraph.
25
Sec.
5.
Section
124E.9,
Code
2019,
is
amended
by
adding
the
26
following
new
subsections:
27
NEW
SUBSECTION
.
13.
A
medical
cannabidiol
dispensary
28
may
employ
a
pharmacist
or
pharmacy
technician
licensed
or
29
registered
pursuant
to
chapter
155A.
30
NEW
SUBSECTION
.
14.
a.
Except
as
otherwise
provided
in
31
paragraph
“b”
,
a
medical
cannabidiol
dispensary
shall
not
32
dispense
more
than
a
combined
total
of
twenty-five
grams
of
33
tetrahydrocannabinol
to
a
patient
and
the
patient’s
primary
34
caregiver
in
a
ninety-day
period.
35
-1-
HF
732
(3)
88
ss/rh/md
1/
2
H.F.
732
b.
The
board
of
medicine
shall
adopt
rules
allowing
the
1
health
care
practitioner
who
originally
certified
a
patient
2
to
receive
a
medical
cannabidiol
registration
card
to
apply
3
for,
and
the
medical
cannabidiol
board
to
expeditiously
and
4
efficiently
grant,
a
waiver
to
permit
the
patient
and
the
5
patient’s
primary
caregiver
to
receive
more
than
a
combined
6
total
of
twenty-five
grams
of
tetrahydrocannabinol
in
a
7
ninety-day
period
if
the
health
care
practitioner
submits
8
documentation
certifying
all
of
the
following:
9
(1)
The
health
care
practitioner
performed
a
physical
10
examination
of
the
patient
and
has
determined
that
twenty-five
11
grams
of
tetrahydrocannabinol
per
ninety-day
period
is
not
an
12
adequate
amount
to
alleviate
the
patient’s
debilitating
medical
13
condition.
14
(2)
The
patient’s
debilitating
medical
condition
is
a
15
terminal
illness
with
a
life
expectancy
of
less
than
one
year.
16
Sec.
6.
Section
124E.11,
subsection
1,
paragraph
b,
17
subparagraph
(1),
subparagraph
division
(c),
Code
2019,
is
18
amended
to
read
as
follows:
19
(c)
To
authorized
employees
of
a
medical
cannabidiol
20
dispensary,
but
only
for
the
purpose
purposes
of
verifying
that
21
a
person
is
lawfully
in
possession
of
a
medical
cannabidiol
22
registration
card
issued
pursuant
to
this
chapter
and
that
a
23
person
has
not
purchased
tetrahydrocannabinol
in
excess
of
the
24
amount
authorized
by
this
chapter
.
25
Sec.
7.
Section
124E.11,
subsection
2,
Code
2019,
is
amended
26
by
adding
the
following
new
paragraph:
27
NEW
PARAGRAPH
.
j.
Collect
and
evaluate
data
on
patient
28
demographics,
effective
treatment
options,
clinical
outcomes,
29
and
quality
of
life
outcomes
for
the
purpose
of
reporting
on
30
the
benefits,
risks,
and
outcomes
encountered
by
patients
with
31
a
debilitating
medical
condition
engaged
in
the
use
of
medical
32
cannabidiol.
33
-2-
HF
732
(3)
88
ss/rh/md
2/
2
